speaker-photo

Luis Michea

Professor at Facultad de Medicina, Universidad de Chile
Dr. Luis Michea is Associate Professor at Facultad de Medicina, Universidad de Chile, Principal Investigator of the Institute of Biomedical Sciences at Facultad de Medicina. Dr. Michea received his MD degree from the Facultad de Medicina (Faculty of Medicine) of the Universidad de Chile and his PhD in Biomedical Sciences of Facultad de Medicina, Universidad de Chile. He completed his post-doctoral training with Dr. Maurice Burg, at the Laboratory of Kidney and Electrolyte Metabolism at the National Institutes of Health, Bethesda. At the present, the focus of Dr Michea’s research is on the role of immune cells in hypertension and hypertension target organ damage and the diagnosis of acute kidney injury using new biomarkers, along with mechanisms of treatment of AKI. He has an active role as an undergraduate and postgraduate professor for medical students, nephrologists, and undergraduate students of other healthcare professions. He has developed institutional academic duties as Research Director and as Academic Director of Facultad de Medicina, Universidad de Chile. He has developed an active role in the Chilean National Science Funding System as a member of study groups (Biology and Medicine) and as Study Group member, Study Group Coordinator, and National Council member. He is an active member of several national and international scientific societies in the area of physiology, hypertension, and nephrology. He has served as the President of the Chilean Society of Hypertension, Director of Research and Academic Director, Facultad de Medicina, Universidad de Chile. He has been an academic consultant and collaborator of the Chilean Ministry of Health (MINSAL) in the design of clinical guidelines for the treatment of patients with hypertension and for the treatment of patients with chronic renal failure. He has been an academic consultant and collaborator of the HEARTS initiative in Chile since 2016. He has received awards and recognition from the Chilean Society of Nephrology, Hypertension and Transplantation, from the Chilean Society of Nephrology and from the Chilean Society of Cardiology.